Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area.
Arcangeli S, Saracino B, Petrongari MG, Gomellini S, Marzi S, Landoni V, Gallucci M, Sperduti I, Arcangeli G. Arcangeli S, et al. Among authors: gomellini s. Radiother Oncol. 2007 Aug;84(2):148-55. doi: 10.1016/j.radonc.2007.06.011. Epub 2007 Aug 9. Radiother Oncol. 2007. PMID: 17692416
DVHs evaluation in brain metastases stereotactic radiotherapy treatment plans.
Pasciuti K, Iaccarino G, Soriani A, Bruzzaniti V, Marzi S, Gomellini S, Arcangeli S, Benassi M, Landoni V. Pasciuti K, et al. Among authors: gomellini s. Radiother Oncol. 2008 Apr;87(1):110-5. doi: 10.1016/j.radonc.2007.12.019. Epub 2008 Jan 18. Radiother Oncol. 2008. PMID: 18207593
Clinical and dosimetric predictors of acute toxicity after a 4-week hypofractionated external beam radiotherapy regimen for prostate cancer: results from a multicentric prospective trial.
Arcangeli S, Strigari L, Soete G, De Meerleer G, Gomellini S, Fonteyne V, Storme G, Arcangeli G. Arcangeli S, et al. Among authors: gomellini s. Int J Radiat Oncol Biol Phys. 2009 Jan 1;73(1):39-45. doi: 10.1016/j.ijrobp.2008.04.005. Epub 2008 Jun 4. Int J Radiat Oncol Biol Phys. 2009. PMID: 18538488 Clinical Trial.
Retrospective comparison of external beam radiotherapy and radical prostatectomy in high-risk, clinically localized prostate cancer.
Arcangeli G, Strigari L, Arcangeli S, Petrongari MG, Saracino B, Gomellini S, Papalia R, Simone G, De Carli P, Gallucci M. Arcangeli G, et al. Among authors: gomellini s. Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):975-82. doi: 10.1016/j.ijrobp.2008.12.045. Epub 2009 Apr 22. Int J Radiat Oncol Biol Phys. 2009. PMID: 19395188 Clinical Trial.
A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer.
Arcangeli G, Saracino B, Gomellini S, Petrongari MG, Arcangeli S, Sentinelli S, Marzi S, Landoni V, Fowler J, Strigari L. Arcangeli G, et al. Among authors: gomellini s. Int J Radiat Oncol Biol Phys. 2010 Sep 1;78(1):11-8. doi: 10.1016/j.ijrobp.2009.07.1691. Epub 2010 Jan 4. Int J Radiat Oncol Biol Phys. 2010. PMID: 20047800 Clinical Trial.
Acute and late toxicity in a randomized trial of conventional versus hypofractionated three-dimensional conformal radiotherapy for prostate cancer.
Arcangeli G, Fowler J, Gomellini S, Arcangeli S, Saracino B, Petrongari MG, Benassi M, Strigari L. Arcangeli G, et al. Among authors: gomellini s. Int J Radiat Oncol Biol Phys. 2011 Mar 15;79(4):1013-21. doi: 10.1016/j.ijrobp.2009.12.045. Epub 2010 May 5. Int J Radiat Oncol Biol Phys. 2011. PMID: 20447774 Clinical Trial.
19 results